Catalyst Wire Dossier Catalyst Wire Dossier

DUEXIS

ibuprofen/famotidine · Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DUEXIS, covering 2015-12-23 to 2015-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis [Phase 4]

See pricing